Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Sees Large Drop in Short Interest

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) was the target of a significant drop in short interest in January. As of January 15th, there was short interest totalling 48,900 shares, a drop of 50.4% from the December 31st total of 98,600 shares. Based on an average daily trading volume, of 129,400 shares, the days-to-cover ratio is presently 0.4 days.

Tevogen Bio Trading Down 11.1 %

Shares of NASDAQ TVGNW traded down $0.01 during trading on Thursday, reaching $0.08. The company had a trading volume of 234,677 shares, compared to its average volume of 185,233. Tevogen Bio has a 12 month low of $0.01 and a 12 month high of $0.28. The company’s fifty day moving average price is $0.06 and its 200-day moving average price is $0.04.

About Tevogen Bio

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.